JP2021515004A5 - - Google Patents
Info
- Publication number
- JP2021515004A5 JP2021515004A5 JP2020545526A JP2020545526A JP2021515004A5 JP 2021515004 A5 JP2021515004 A5 JP 2021515004A5 JP 2020545526 A JP2020545526 A JP 2020545526A JP 2020545526 A JP2020545526 A JP 2020545526A JP 2021515004 A5 JP2021515004 A5 JP 2021515004A5
- Authority
- JP
- Japan
- Prior art keywords
- propanamide
- oxy
- dimethyl
- pyridine
- methylpiperidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023098091A JP2023134444A (ja) | 2018-03-01 | 2023-06-14 | ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート |
| JP2025016827A JP2025084759A (ja) | 2018-03-01 | 2025-02-04 | ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862637295P | 2018-03-01 | 2018-03-01 | |
| US62/637,295 | 2018-03-01 | ||
| PCT/US2019/020086 WO2019169153A1 (en) | 2018-03-01 | 2019-02-28 | Piperidinyl-3-(aryloxy)propanamides and propanoates |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023098091A Division JP2023134444A (ja) | 2018-03-01 | 2023-06-14 | ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021515004A JP2021515004A (ja) | 2021-06-17 |
| JP2021515004A5 true JP2021515004A5 (cg-RX-API-DMAC7.html) | 2022-03-10 |
| JP7297776B2 JP7297776B2 (ja) | 2023-06-26 |
Family
ID=65763866
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020545526A Active JP7297776B2 (ja) | 2018-03-01 | 2019-02-28 | ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート |
| JP2023098091A Pending JP2023134444A (ja) | 2018-03-01 | 2023-06-14 | ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート |
| JP2025016827A Pending JP2025084759A (ja) | 2018-03-01 | 2025-02-04 | ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023098091A Pending JP2023134444A (ja) | 2018-03-01 | 2023-06-14 | ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート |
| JP2025016827A Pending JP2025084759A (ja) | 2018-03-01 | 2025-02-04 | ピペリジニル－３－（アリールオキシ）プロパンアミド及びプロパノエート |
Country Status (22)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI834637B (zh) * | 2018-03-01 | 2024-03-11 | 日商武田藥品工業有限公司 | 六氫吡啶基-3-(芳氧基)丙醯胺及丙酸酯 |
| GB201901559D0 (en) * | 2019-02-05 | 2019-03-27 | Syngenta Crop Protection Ag | Herbicidal compositions |
| WO2021143680A1 (zh) | 2020-01-16 | 2021-07-22 | 浙江海正药业股份有限公司 | 杂芳基类衍生物及其制备方法和用途 |
| AR121682A1 (es) * | 2020-03-31 | 2022-06-29 | Takeda Pharmaceuticals Co | Derivados de n-(heterociclil y heterociclilalquil)-3-bencilpiridin-2-amina como agonistas de sstr4 |
| AR121683A1 (es) * | 2020-03-31 | 2022-06-29 | Takeda Pharmaceuticals Co | Derivados de n-heteroarilalquil-2-(heterociclil y heterociclilmetil)acetamida como agonistas de sstr4 |
| WO2021233428A1 (zh) * | 2020-05-21 | 2021-11-25 | 广州费米子科技有限责任公司 | 含氮饱和杂环化合物及其制备方法、药物组合物和应用 |
| IL300893A (en) * | 2020-08-24 | 2023-04-01 | Hua Medicine Shanghai Ltd | Preparation of modified acrylate compounds |
| EP4304586A4 (en) | 2021-03-10 | 2025-04-02 | Jnana Therapeutics Inc. | SMALL MOLECULE INHIBITORS OF MAMMALIAN SLC6A19 FUNCTION |
| CN115477640A (zh) * | 2021-05-31 | 2022-12-16 | 由理生物医药（上海）有限公司 | 作为parp7抑制剂的哒嗪酮类化合物 |
| KR20240169050A (ko) * | 2022-03-30 | 2024-12-02 | 다케다 야쿠힌 고교 가부시키가이샤 | N-(피롤리딘-3-일 또는 피페리딘-4-일)아세트아마이드 유도체 |
| WO2025247982A1 (en) | 2024-05-29 | 2025-12-04 | Grünenthal GmbH | Piperazines which act as sstr4 modulators |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| GB9518953D0 (en) | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
| GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| SE9902987D0 (sv) * | 1999-08-24 | 1999-08-24 | Astra Pharma Prod | Novel compounds |
| CN1960970A (zh) * | 2004-05-28 | 2007-05-09 | 田边制药株式会社 | 作为cb1受体的拮抗剂的吡咯烷衍生物 |
| TW200602314A (en) | 2004-05-28 | 2006-01-16 | Tanabe Seiyaku Co | A novel pyrrolidine compound and a process for preparing the same |
| CN101163676A (zh) | 2005-02-23 | 2008-04-16 | 普雷萨药品公司 | 用于治疗运动障碍及其它cns适应症的多巴胺转运蛋白抑制剂 |
| ES2330788T3 (es) | 2005-06-02 | 2009-12-15 | F. Hoffmann-La Roche Ag | Derivados de piperidin-4-il-amida y su uso como antagonistas del subtipo 5 del receptor sst. |
| JP4943826B2 (ja) * | 2005-11-25 | 2012-05-30 | 田辺三菱製薬株式会社 | 医薬組成物 |
| JP5736098B2 (ja) * | 2007-08-21 | 2015-06-17 | アッヴィ・インコーポレイテッド | 中枢神経系障害を治療するための医薬組成物 |
| JP5509104B2 (ja) * | 2008-03-14 | 2014-06-04 | エグゼリクシス， インコーポレイテッド | １１β−ＨＳＤ１モジュレータとしてのアザビシクロ［３．２．１］オクチル誘導体 |
| WO2010059922A1 (en) | 2008-11-21 | 2010-05-27 | Ligand Pharmaceuticals Incorporated | Pyrrolidine carboxamide compounds |
| BR112012008147A2 (pt) | 2009-09-04 | 2016-03-01 | Novartis Ag | compostos heteroarílicos como inibidores da quinase |
| US9371282B2 (en) | 2013-05-17 | 2016-06-21 | Centrexion Therapeutics Corporation | Somatostatin receptor subtype 4 (SSTR4) agonists |
| EP3045448A4 (en) * | 2013-09-12 | 2017-01-25 | Sumitomo Chemical Company Limited | Nitrogen-containing saturated heterocyclic compound |
| BR112017009595A2 (pt) * | 2014-11-14 | 2017-12-19 | Boehringer Ingelheim Int | morfolina e 1,4-oxazepano amidas como agonistas do subtipo de receptor de somatostatina 4 (sstr4) |
| US9957267B2 (en) | 2015-07-01 | 2018-05-01 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| TWI834637B (zh) * | 2018-03-01 | 2024-03-11 | 日商武田藥品工業有限公司 | 六氫吡啶基-3-(芳氧基)丙醯胺及丙酸酯 |
-
2019
- 2019-02-27 TW TW108106689A patent/TWI834637B/zh active
- 2019-02-28 IL IL276998A patent/IL276998B2/en unknown
- 2019-02-28 BR BR112020017644-3A patent/BR112020017644A2/pt unknown
- 2019-02-28 US US16/289,311 patent/US11045457B2/en active Active
- 2019-02-28 PE PE2020001318A patent/PE20211313A1/es unknown
- 2019-02-28 MY MYPI2020004443A patent/MY206763A/en unknown
- 2019-02-28 SG SG11202008398XA patent/SG11202008398XA/en unknown
- 2019-02-28 AR ARP190100507A patent/AR114421A1/es unknown
- 2019-02-28 JP JP2020545526A patent/JP7297776B2/ja active Active
- 2019-02-28 EP EP19710934.1A patent/EP3759094A1/en active Pending
- 2019-02-28 EA EA202092054A patent/EA202092054A1/ru unknown
- 2019-02-28 CN CN201980026854.8A patent/CN112236423B/zh active Active
- 2019-02-28 AU AU2019228568A patent/AU2019228568B2/en active Active
- 2019-02-28 CA CA3092450A patent/CA3092450A1/en active Pending
- 2019-02-28 KR KR1020207028006A patent/KR102822276B1/ko active Active
- 2019-02-28 UA UAA202005559A patent/UA126829C2/uk unknown
- 2019-02-28 KR KR1020257019753A patent/KR20250094741A/ko active Pending
- 2019-02-28 MX MX2020009062A patent/MX2020009062A/es unknown
- 2019-02-28 WO PCT/US2019/020086 patent/WO2019169153A1/en not_active Ceased
-
2020
- 2020-08-29 PH PH12020551359A patent/PH12020551359A1/en unknown
- 2020-08-31 ZA ZA2020/05438A patent/ZA202005438B/en unknown
- 2020-09-01 CL CL2020002257A patent/CL2020002257A1/es unknown
- 2020-10-01 EC ECSENADI202062464A patent/ECSP20062464A/es unknown
-
2021
- 2021-05-14 US US17/320,574 patent/US12005054B2/en active Active
-
2023
- 2023-06-14 JP JP2023098091A patent/JP2023134444A/ja active Pending
-
2024
- 2024-05-07 US US18/657,004 patent/US20250049772A1/en active Pending
-
2025
- 2025-02-04 JP JP2025016827A patent/JP2025084759A/ja active Pending